Arlene Chow, a first-chair Chambers-ranked litigator and trial lawyer, represents companies in the life sciences, pharmaceutical, and biotech industries on patent, trade secret, and licensing disputes. She serves as Global Vice Chair of the firm’s Healthcare & Life Sciences Industry Group.
Arlene routinely litigates IP matters directed to small molecule and biologic drugs for the treatment of a wide variety of indications, as well as medical devices and dosage forms. Leveraging her background in biochemistry, Arlene is able to frame matters from the perspective of a judge or jury in order to achieve the best solutions for her clients. Arlene thrives on interaction with scientific experts, both in-house and externally.
Arlene is a United States Patent and Trademark Office (USPTO) registered patent attorney, and one of a select few who has been first-chair not only in district court trials and hearings, but also federal circuit arguments, and inter partes and post grant review hearings before the USPTO.
Arlene won the 2023 LMG Life Sciences Post-Grant Proceedings Attorney of the Year. She was shortlisted in the 2021 LMG Life Sciences Awards as General Patent Litigator of the Year for New York. In 2023, Arlene was named one of the Notable Women in Law by Crain’s New York Business, a Woman Worth Watching in STEM by Diversity Journal, and one of the Top 250 Women in IP by Managing IP.
Arlene previously served as Co-Chair of the firm’s WEB Committee in the New York office.
Arlene’s experience includes representing:
*Matter handled prior to joining Latham
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.
Recognitions include Impact Deal of the Year and Patent Impact Case of the Year.
Arlene Chow, Rachel Cohen, and Betty Pang honored by Profiles in Diversity Journal for their talent, leadership, and forward thinking.